Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,017 Cr₹853 Cr₹71 Cr₹617 Cr₹5,123 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,017 Cr
Mar2024₹853 Cr
Mar2023₹71 Cr
Mar2022₹617 Cr
Mar2021₹5,123 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹1,017 Cr
19.20
Mar2024 ₹853 Cr
1,096.71
Mar2023 ₹71 Cr
-88.44
Mar2022 ₹617 Cr
-87.96
Mar2021 ₹5,123 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,425.4 Cr 8.7% -2.8% -43.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

8.7%

-2.8%

-43.4%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses